(4-Cyclopropylphenyl)methanamine hydrochloride is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive compounds. It plays a significant role in the creation of molecules targeting neurological disorders, particularly in the development of drugs that interact with neurotransmitter systems. Its structural framework is valuable for designing compounds with potential antidepressant, anxiolytic, or antipsychotic properties. Additionally, this chemical is explored in medicinal chemistry for its potential in modulating receptor activity, making it a crucial component in the discovery of novel therapeutic agents.